| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |